Clinical trial
A Randomised, Controlled, Parallel-group, Open-label Study to Evaluate Different Dosing Regimens of Rabeprazole in Controlling Nocturnal Heartburn Symptoms in Patients With Gastroesophageal Reflux Disease.
NCT00553449 is registered in ClinicalTrials.gov with Janssen-Ortho Inc., Canada as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Controlled, Parallel-group, Open-label Study to Evaluate Different Dosing Regimens of Rabeprazole in Controlling Nocturnal Heartburn Symptoms in Patients With Gastroesophageal Reflux Disease.
- Lead sponsor
- Janssen-Ortho Inc., Canada
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2004
- Completion date
- September 30, 2005
- Enrollment
- 48 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.